Risks of venous thromboembolism after cesarean sections: a meta-analysis

Authors

  • Marc Blondon Geneva University Hospitals and Faculty of Medicine, Switzerland
  • Alessandro Casini Geneva University Hospitals and Faculty of Medicine, Switzerland
  • Kara K. Hoppe University of Wisconsin, Madison, USA; University of Washington, Seattle, USA, United States

DOI:

https://doi.org/10.18370/2309-4117.2016.31.73-79

Keywords:

deep venous thrombosis, pulmonary embolism, pregnancy, meta analysis

Abstract

Background: Cesarean sections (CS) are believed to be associated with greater risks of postpartum venous thromboembolism (VTE). Our objective was to systematically review the evidence on this association and on the absolute risk of VTE after CS.

Methods: Authors searched PubMed, Embase and conference proceedings from 1980 to 11/2015 for reports on the associations of delivery methods with postpartum VTE and on the incidence of VTE after CS. They excluded studies on thrombophilia or recurrent VTE and restricted to prospective studies when assessing the incidence of VTE. Pooled relative and absolute risks were estimated with random-effects models.

Results: search retrieved 28 mostly retrospective observational studies comparing risks of VTE after CS and after vaginal deliveries (VD) (n > 53 000 VTE events), and 32 prospective studies reporting risks of VTE after CS (n = 218 VTE events). Compared with VD, the relative risk of VTE after CS ranged from 1–22, with a meta-analytic odds ratio (OR) of 3.7 (95% CI 3.0–4.6). Adjustment for age and BMI had a marginal influence on the estimated pooled OR.

Associations were observed for both elective and emergency CS, with stronger estimates of associations for emergency CS. The pooled incidence was 2.6 VTE/1000 CS (95% CI 1.7–3.5), and was greater in studies with a longer and better follow-up in the postpartum (4.3/1000 CS).

Conclusion: The risk of VTE is 4-fold greater after CS than VD, appears independent of other VTE risk factors, and is greater after emergency than elective CS. On average, 3 in 1000 women will develop a VTE after CS.

Author Biographies

Marc Blondon, Geneva University Hospitals and Faculty of Medicine

MD, MS, Division of Angiology and Hemostasis, Department of Specialties of Medicine

Alessandro Casini, Geneva University Hospitals and Faculty of Medicine

MD, Division of Angiology and Hemostasis, Department of Specialties of Medicine

Kara K. Hoppe, University of Wisconsin, Madison, USA; University of Washington, Seattle, USA

DO, Department of Obstetrics and Gynecology and of Maternal Fetal Medicine;

Department of Obstetrics and Gynecology

References

  1. Pomp, E.R., Lenselink, A.M., Rosendaal, F.R., Doggen, C.J.M. “Pregnancy, the postpartum period and prothrombotic defects: Risk of venous thrombosis in the MEGA study.” Journal of Thrombosis and Haemostasis 6.4 (2008): 632–7.
  2. Wik, H.S., Jacobsen, A.F., Sandvik, L., Sandset, P.M. “Prevalence and predictors for postthrombotic syndrome 3 to 16 years after pregnancy-related venous thrombosis: a population-based, cross-sectional, case-control study.” Journal of thrombosis and haemostasis: JTH 10.5 (2012): 840–7.
  3. Martin, J.A., Hamilton, B.E., Osterman, M.J. “Births in the United States, 2013.” NCHS Data Brief 175 (2014): 1–8.
  4. Jacobsen, A.F., Skjeldestad, F.E., Sandset, P.M. “Ante- and postnatal risk factors of venous thrombosis: a hospital-based case-control study.” Journal of thrombosis and haemostasis: JTH 6.6 (2008): 905–12.
  5. Stroup, D.F., Berlin, J.A., Morton, S.C., et al. “Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group.” Jama 283.15 (2000): 2008–12.
  6. Wells, G., Shea, B., O’Connell, J., et al. “The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analysis.” Available from: [http://www.ohri.ca/programs/clinical_epidemiology/oxford. asp], last accessed Aug 24, 2016.
  7. Trinquart, L., Touze, E. “Pitfalls in meta-analysis of observational studies: lessons from a systematic review of the risks of stenting for intracranial atherosclerosis.” Stroke 40.10 (2009): e586–90.
  8. James, A.H., Jamison, M.G., Brancazio, L.R., Myers, E.R. “Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality.” American journal of obstetrics and gynecology 194.5 (2006): 1311–5.
  9. Abbasi, N., Balayla, J., Laporta, D.P., et al. “Trends, risk factors and mortality among women with venous thromboembolism during labour and delivery: A populationbased study of 8 million births.” Archives of gynecology and obstetrics 289.2 (2014): 275–84.
  10. Macklon, N.S., Greer, I.A. “Venous thromboembolic disease in obstetrics and gynaecology: the Scottish experience.” Scottish medical journal 41.3 (1996): 83–6.
  11. Treffers, P.E., Huidekoper, B.L., Weenink, G.H., et al. “Epidemiological observations of thrombo-embolic disease during pregnancy and in the puerperium, in 56,022 women.” International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 21.4 (1983): 327–31.
  12. Galanaud, J.P., Cochery-Nouvellon, E., Alonso, S., et al. “Paternal endothelial protein C receptor 219Gly variant as a mild and limited risk factor for deep vein thrombosis during pregnancy.” Journal of thrombosis and haemostasis: JTH 8.4 (2010): 707–13.
  13. Hiltunen, L., Rautanen, A., Rasi, V., et al. “An unfavorable combination of Factor V Leiden with age, weight, and blood group causes high risk of pregnancyassociated venous thrombosis: a population-based nested casecontrol study.” Thrombosis research 119.4 (2007): 423–32.
  14. Jacobsen, A.F., Skjeldestad, F.E., Sandset, P.M. “Incidence and risk patterns of venous thromboembolism in pregnancy and puerperium – a register-based case-control study.” American journal of obstetrics and gynecology 198.2 (2008): e231–237.
  15. Landon, M.B., Hauth, J.C., Leveno, K.J., et al. “Maternal and perinatal outcomes associated with a trial of labor after prior cesarean delivery.” N Engl J Med 351.25 (2004): 2581–9.
  16. Virkus, R.A., Lokkegaard, E., Lidegaard, O., et al. “Risk factors for venous thromboembolism in 1.3 million pregnancies: a nationwide prospective cohort.” PloS one 9.5 (2014): e96495.
  17. Abdul Sultan, A., Grainge, M.J., West, J., et al. “Impact of risk factors on the timing of first postpartum venous thromboembolism: a population-based cohort study from England.” Blood 124.18 (2014): 2872–80.
  18. Blondon, M., Harrington, L.B., Righini, M., et al. “Racial and ethnic differences in the risk of postpartum venous thromboembolism: a population-based, case-control study.” Journal of thrombosis and haemostasis: JTH 12.12 (2014): 2002–9.
  19. Colmorn, L.B., Ladelund, S., Rasmussen, S., Secher, N.J. “Risk of a venous thromboembolic episode due to caesarean section and BMI: A study in northern Denmark covering 2000–2010.” Journal of Obstetrics and Gynaecology 34.4 (2014): 313–6.
  20. Sultan, A.A., Tata, L.J., West, J., et al. “Risk factors for first venous thromboembolism around pregnancy: a population-based cohort study from the United Kingdom.” Blood 121.19 (2013): 3953–61.
  21. Danilenko-Dixon, D.R., Heit, J.A., Silverstein, M.D., et al. “Risk factors for deep vein thrombosis and pulmonary embolism during pregnancy or post partum: A populationbased, casecontrol study.” American Journal of Obstetrics and Gynecology 184.2 (2001): 104–10.
  22. Kierkegaard, A. “Incidence and diagnosis of deep vein thrombosis associated with pregnancy.” Acta obstetricia et gynecologica Scandinavica 62.3 (1983): 239–43.
  23. Koroukian, S.M. “Relative risk of postpartum complications in the Ohio Medicaid population: Vaginal versus cesarean delivery.” Medical Care Research and Review 61.2 (2004): 203–24.
  24. Lindqvist, P.G., Torsson, J., Almqvist, A., Bjorgell, O. “Postpartum thromboembolism: severe events might be preventable using a new risk score model.” Vascular health and risk management 4.5 (2008): 1081–7.
  25. Kobayashi, T., Nakabayashi, M., Ishikawa, M., et al. “Pulmonary thromboembolism in obstetrics and gynecology increased by 6.5-fold over the past decade in Japan.” Circulation journal : official journal of the Japanese Circulation Society 72.5 (2008): 753–6.
  26. Burrows, L.J., Meyn, L.A., Weber, A.M. “Maternal morbidity associated with vaginal versus cesarean delivery.” Obstetrics and gynecology 103 (5 Pt 1) (2004): 907–12.
  27. Chan, L.Y., Tam, W.H., Lau, T.K. “Venous thromboembolism in pregnant Chinese women.” Obstetrics and gynecology 98.3 (2001): 471–5.
  28. Gherman, R.B., Goodwin, T.M., Leung, B., et al. “Incidence, clinical characteristics, and timing of objectively diagnosed venous thromboembolism during pregnancy.” Obstetrics and gynecology 94 (5 Pt 1) (1999): 730–4.
  29. Simpson, E.L., Lawrenson, R.A., Nightingale, A.L., et al. “Venous thromboembolism in pregnancy and the puerperium: Incidence and additional risk factors from a London perinatal database.” British Journal of Obstetrics and Gynaecology 108.1 (2001): 56–60.
  30. Won, H.S., Kim do, Y., Yang, M.S., et al. “Pregnancy-induced hypertension, but not gestational diabetes mellitus, is a risk factor for venous thromboembolism in pregnancy.” Korean Circ J 41.1 (2011): 23–7.
  31. Lindqvist, P., Dahlback, B., Marsal, K. “Thrombotic risk during pregnancy: a population study.” Obstetrics and gynecology 94.4 (1999):595–9.
  32. Liu, S., Rouleau, J., Joseph, K.S., et al. “Epidemiology of pregnancy-associated venous thromboembolism: a population-based study in Canada.” Journal of obstetrics and gynaecology Canada: JOGC 31.7 (2009): 611–20.
  33. Ghaji, N., Boulet, S.L., Tepper, N., Hooper, W.C. “Trends in venous thromboembolism among pregnancy-related hospitalizations, United States, 1994-2009.” American Journal of Obstetrics and Gynecology 209.5 (2013): e431–438.
  34. Kane, E.V., Calderwood, C., Dobbie, R., et al. “A populationbased study of venous thrombosis in pregnancy in Scotland 1980–2005.” European Journal of Obstetrics Gynecology and Reproductive Biology 169.2 (2013): 223–9.
  35. Morris, J.M., Algert, C.S., Roberts, C.L. “Incidence and risk factors for pulmonary embolism in the postpartum period.” Journal of thrombosis and haemostasis: JTH 8.5 (2010): 998–1003.
  36. Pallasmaa, N., Ekblad, U., Gissler, M. “Severe maternal morbidity and the mode of delivery.” Acta Obstetricia et Gynecologica Scandinavica 87.6 (2008): 662–8.
  37. Chauleur, C., Quenet, S., Varlet, M.N., et al. “Feasibility of an easy-to-use risk score in the prevention of venous thromboembolism and placental vascular complications in pregnant women: a prospective cohort of 2736 women.” Thrombosis research 122.4 (2008): 478–84.
  38. Silver, R.M., Landon, M.B., Rouse, D.J., et al. “Maternal morbidity associated with multiple repeat cesarean deliveries.” Obstetrics and gynecology 107.6 (2006): 1226–32.
  39. Burrows, R.F., Gan, E.T., Gallus, A.S., et al. “A randomised doubleblind placebo controlled trial of low molecular weight heparin as prophylaxis in preventing venous thrombolic events after caesarean section: a pilot study.” BJOG: an international journal of obstetrics and gynaecology 108.8 (2001): 835–9.
  40. Cavazza, S., Rainaldi, M.P., Adduci, A., Palareti, G. “Thromboprophylaxis following cesarean delivery: one site prospective pilot study to evaluate the application of a risk score model.” Thrombosis research 129.1 (2012): 28–31.
  41. Gates, S., Brocklehurst, P., Ayers, S., Bowler, U. “Thromboprophylaxis and pregnancy: two randomized controlled pilot trials that used low-molecular-weight heparin.” American journal of obstetrics and gynecology 191.4 (2004): 1296–303.
  42. Gizzo, S., Noventa, M., Anis, O., et al. “Pharmacological anti-thrombotic prophylaxis after elective caesarean delivery in thrombophilia unscreened women: Should maternal age have a role in decision making?” Journal of Perinatal Medicine 42.3 (2014): 339–47.
  43. Kalro, B.N., Davidson, R.A., Owen, P. “Low incidence of asymptomatic deep venous thrombosis following caesarean section: a colour Doppler study.” Health bulletin 57.6 (1999): 418–21.
  44. Larsson, C., Saltvedt, S., Wiklund, I., Andolf, E. “Planned vaginal delivery versus planned caesarean section: short-term medical outcome analyzed according to intended mode of delivery.” Journal of obstetrics and gynaecology Canada: JOGC 33.8 (2011): 796–802.
  45. Lindqvist, P.G., Svensson, P.J., Marsal, K., et al. “Activated protein C resistance (FV:Q506) and pregnancy.” Thrombosis and Haemostasis 81.4 (1999): 532–7.
  46. Salomon, O., Seligsohn, U., Steinberg, D.M., et al. “The common prothrombotic factors in nulliparous women do not compromise blood flow in the feto-maternal circulation and are not associated with preeclampsia or intrauterine growth restriction.” American journal of obstetrics and gynecology 191.6 (2004): 2002–9.
  47. Hager, R.M., Daltveit, A.K., Hofoss, D., et al. “Complications of cesarean deliveries: rates and risk factors.” American journal of obstetrics and gynecology 190.2 (2004): 428–34.
  48. Pallasmaa, N., Ekblad, U., Aitokallio-Tallberg, A., et al. “Cesarean delivery in Finland: Maternal complications and obstetric risk factors.” Acta Obstetricia et Gynecologica Scandinavica 89.7 (2010): 896–902.
  49. Chan, L.Y., Lam, K.Y., Metreweli, C., Lau, T.K. “Duplex ultrasound screening for deep vein thrombosis in Chinese after cesarean section.” Acta obstetricia et gynecologica Scandinavica 84.4 (2005): 368–70.
  50. Goto, M., Yoshizato, T., Tatsumura, M., et al. “Safety and efficacy of thromboprophylaxis using enoxaparin sodium after cesarean section: A multi-center study in Japan.” Taiwanese journal of obstetrics & gynecology 54.3 (2015): 248–52.
  51. Jacobsen, A.F., Drolsum, A., Klow, N.E., et al. “Deep vein thrombosis after elective cesarean section.” Thrombosis research 113.5 (2004):283–8.
  52. Macklon, N.S., Barry, J., Greer, I.A. “Duplex ultrasound screening for deep venous thrombosis in the puerperium.” British journal of obstetrics and gynaecology 102.3 (1995): 255–6.
  53. Rodger, M.A., Avruch, L.I., Howley, H.E., et al. “Pelvic magnetic resonance venography reveals high rate of pelvic vein thrombosis after cesarean section.” American journal of obstetrics and gynecology 194.2 (2006): 436–7.
  54. Sia, W.W., Powrie, R.O., Cooper, A.B., et al. “The incidence of deep vein thrombosis in women undergoing cesarean delivery.” Thrombosis research 123.3 (2009): 550–5.
  55. Clark, P., Walker, I.D., Govan, L., Wu, O., Greer, I.A. “The GOAL study: a prospective examination of the impact of factor V Leiden and ABO(H) blood groups on haemorrhagic and thrombotic pregnancy outcomes.” British journal of haematology 140.2 (2008): 236–40.
  56. Hannah, M.E., Hannah, W.J., Hewson, S.A., et al. Planned caesarean section versus planned vaginal birth for breech presentation at term: a randomised multicentre trial. Term Breech Trial Collaborative Group.” Lancet 356.9239 (2000):1375–83.
  57. Raees, M., Yasmeen, S., Jabeen, S., et al. “Maternal morbidity associated with emergency versus elective caesarean section.” Journal of Postgraduate Medical Institute 27.1 (2013): 55–62.
  58. Said, J.M., Higgins, J.R., Moses, E.K., et al. “Inherited thrombophilia polymorphisms and pregnancy outcomes in nulliparous women.” Obstetrics and gynecology 115.1 (2010): 5–13.
  59. Sharma, R., Atkin, H., Mackillop, L., Paterson-Brown, S. “Assessment of the mobility of mothers postpartum to identify those at greatest risk of venous thromboembolism.” J Obstet Gynaecol 32.5 (2012): 461–3.
  60. Hill, N.C., Hill, J.G., Sargent, J.M., et al. “Effect of low dose heparin on blood loss at caesarean section.” British medical journal (Clinical research ed.) 296.6635 (1988): 1505–6.
  61. Masliah-Planchon, R., Lavigne, F., Claquin, C., et al. “Systematic prevention of deep vein thrombosis with subcutaneous heparin therapy following cesarean section. Advantages and disadvantages.” Journal de gynecologie, obstetrique et biologie de la reproduction 12.1 (1983): 95–100.
  62. Jackson, E., Curtis, K.M., Gaffield, M.E. “Risk of venous thromboembolism during the postpartum period: a systematic review.” Obstetrics and gynecology 117.3 (2011): 691–703.
  63. Abdul Sultan, A., Tata, L.J., Grainge, M.J., West, J. “The incidence of first venous thromboembolism in and around pregnancy using linked primary and secondary care data: a population based cohort study from England and comparative meta-analysis.” PloS one 8.7 (2013): e70310.
  64. Epiney, M., Boehlen, F., Boulvain, M., et al. “D-dimer levels during delivery and the postpartum.” Journal of thrombosis and haemostasis: JTH 3.2 (2005): 268–71.
  65. Friedman, A.M., Ananth, C.V., Lu, Y.S., et al. “Underuse of postcesarean thromboembolism prophylaxis.” Obstetrics and gynecology 122.6 (2013): 1197–204.
  66. Alalaf, S.K., Jawad, R.K., Muhammad, P.R., et al. “Bemiparin versus enoxaparin as thromboprophylaxis following vaginal and abdominal deliveries: A prospective clinical trial.” BMC Pregnancy and Childbirth 15.1 (2015).
  67. James, A., Committee on Practice B-O. “Practice bulletin No. 123: thromboembolism in pregnancy.” Obstetrics and gynecology 118.3 (2011): 718–29.
  68. Bates, S.M., Greer, I.A., Middeldorp, S., et al. “VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.” Chest 141 (2 Suppl) (2012): e691S–736S.
  69. Gynaecologists RCoO. Reducing the Risk of Venous Thromboembolism during Pregnancy and the Puerperium. Green-top Guideline No. 37a. 2015.
  70. Blondon, M., Perrier, A., Nendaz, M., et al. “Thromboprophylaxis with low-molecularweight heparin after cesarean delivery.” Thrombosis and haemostasis 103.1 (2010): 129–37.

Downloads

Published

2016-10-21

How to Cite

Blondon, M., Casini, A., & Hoppe, K. K. (2016). Risks of venous thromboembolism after cesarean sections: a meta-analysis. REPRODUCTIVE ENDOCRINOLOGY, (31), 73–79. https://doi.org/10.18370/2309-4117.2016.31.73-79

Issue

No. 31 (2016)

Section

Pregnancy and childbirth

License

Copyright (c) 2016 Marc Blondon, Alessandro Casini, Kara K. Hoppe

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

    1. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.